{"id":"W2112629007","doi":"10.1007/s00403-006-0660-6","title":"The long-term efficacy and safety of new biological therapies for psoriasis","year":2006,"lang":"en","type":"review","venue":"Archives of Dermatological Research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Probity Medical Research","funders":"","keywords":"Efalizumab; Etanercept; Medicine; Psoriasis; Infliximab; Psoriasis Area and Severity Index; Clinical trial; Internal medicine; Dermatology; Plaque psoriasis; Disease; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070125,0.0004026829,0.001839912,0.0002448104,0.0004779287,0.00002329975,0.0008868607,0.0006243552,0.00004175262],"category_scores_gemma":[0.0007828483,0.0001962416,0.0006588009,0.0002515887,0.002328159,0.00002498143,0.0004137335,0.0005081848,0.00002141418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001387769,"about_ca_system_score_gemma":0.0002260428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001800239,"about_ca_topic_score_gemma":0.00001015739,"domain_scores_codex":[0.9958236,0.001837894,0.0009502486,0.0005412028,0.0001111073,0.0007358958],"domain_scores_gemma":[0.9785232,0.020489,0.000346284,0.0005086428,0.00007138538,0.00006147343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007729474,0.0002187959,0.0008286549,0.001458395,0.0008994924,0.000006963934,0.00008967476,3.106597e-8,0.00009122515,0.003620051,0.000618119,0.9913957],"study_design_scores_gemma":[0.002795529,0.0008530662,0.01619529,0.002120651,0.0004972563,0.0001571965,0.00004202749,2.089838e-7,0.0005217034,0.003310858,0.9731622,0.0003440538],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003801932,0.9932724,0.00007383458,0.0001257355,0.0001346731,0.001711501,0.0002469601,0.00002552627,0.0006074853],"genre_scores_gemma":[0.003872989,0.9941567,0.000248969,0.000003724576,0.00005353296,0.0001836006,0.000428048,0.00002351655,0.001028895],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9910516,"threshold_uncertainty_score":0.8578199,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1448395228925136,"score_gpt":0.3969068325830045,"score_spread":0.2520673096904908,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}